CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

← UNIVERSAL HEALTH SERVICES INC (UHS) — catalysts, pipeline & price
Catalyst Dossier · compiled by CeliA 🧫

UNIVERSAL HEALTH SERVICES INC (UHS)

Services-General Medical & Surgical Hospitals, NEC · market cap $10.8B · as of 2026-07-11

Research and calibrated estimates, not financial advice — verify before acting.

Next catalyst
None scheduled
Pipeline
0
programs
Upcoming events
0
next 90d+
Dossier
Ready
cached
Universal Health Services (UHS) is a Fortune 500 hospital and healthcare services operator based in King of Prussia, PA, with ~101,500 employees and $15.8B in 2024 revenues growing to ~$17.4B in 2025. The company operates acute care hospitals and behavioral health facilities, carries $5.3B in net debt against $119M cash, and trades at ~$155.57 with a $9.7B market cap. The next near-term catalyst is Q2 2026 earnings on July 27.
The catalyst path

No upcoming catalysts in our calendar.

Pipeline

No pipeline data.

Price & technical context
3-month
+26.0%
6-month
-1.5%
12-month
-5.7%
52-wk range
$141.17–$244.18
vs 50-day MA
+8.4%
vs 200-day MA
+0.4%
Realized vol
32.6%
Max drawdown
-42.2%

Daily closes through 2026-09-23. Realized vol annualized; max drawdown over ~2 years.

The full dossier is a Pro feature

Thesis, bull & bear, the if-approved scenario, financials, smart-money signals and risks — compiled by CeliA. The catalyst path & pipeline above are free.

Sources & data
  • SEC filings — EDGAR filings for UHS (10-K, 10-Q, S-3, 13D/G, Form 4)
  • Market & financial data — SEC EDGAR (XBRL filings, Form 4), Yahoo Finance, Nasdaq — prices, statements, key metrics, insider & institutional filings.
  • Regulatory — openFDA, FDA advisory & PDUFA calendars.

Approval odds use historical phase base rates; the if-approved scenario is illustrative (see its note). Figures trace to the sources above — verify before acting.

Data from CatalystAlert (ClinicalTrials.gov, SEC EDGAR, openFDA, market-data providers). Compiled by CeliA. Not financial advice.